A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies

M. V. Seiden, H. A. Burris, U. Matulonis, J. B. Hall, D. K. Armstrong, J. Speyer, J. D.A. Weber, F. Muggia

Research output: Contribution to journal › Article › peer-review

105 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences